Delivery Order SPE2DB20D9331-SPE2DB25FL0M4

Award Date 1/10/25
Potential Completion Date 2/3/25
Potential Value $118K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $55,229.58, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order, is for the supply of 3,750 units of a 5 ml vial of the medication ASPARLAS. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This federal contract award, valued at $27,614.78, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which is a firm-fixed price delivery order under the DLA's SPE2DB program, is for the supply of 3,750 units of the pharmaceutical product ASPARLAS 3,750 UNIT/5 ML VIAL 5ML. This award does not have a set-aside designation. DMS Pharmaceutical Group holds a...
This federal contract award, valued at $52,599.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 3,750 units of the pharmaceutical product ASPARLAS (5 ml vial). The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA), a major supply chain management agency within the Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $55,229.58, is a firm fixed-price delivery order under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA. This IDC, part of the DLA's SPE2DB program, allows the...
The U.S. Defense Logistics Agency (DLA) awarded a $55,229.58 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 3,750 units of the 5 ML vial pharmaceutical product ASPARLAS. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract #SPE2DB22D9367 with DLA, which has a ceiling value of up to $4,999,999 and enables DLA to order a broad...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $110,459.16 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 3,750 units of the 5 ML ASPARLAS (asparaginase erwinia chrysanthemi) vial to support the medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,614.78, is for the delivery of 3,750 units of the drug ASPARLAS (5 mL vials) with a completion date of May 17, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to supply 3,750 units of ASPARLAS 3,750 UNIT/5 ML VIAL 5ML pharmaceutical products. The delivery order, valued at one hundred five thousand one hundred ninety-nine dollars and twenty cents ($105,199.20), has a completion date of December 27, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group Inc. will fulfill the...
This federal contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $52,599.60, is a delivery order under the SPE2DB program, which is a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999 and valid through November 2026. The contract is for the supply of 3,750 units of the pharmaceutical product ASPARLAS,...
The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 3,750 units of the 5 milliliter vial of the pharmaceutical product ASPARLAS. The total potential value of the order is $82,844.34. The contract has a completion date of February 7, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a range of brand and generic prescription and over-the-counter drug supplies to...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL0M4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $118,467.44 firm fixed-price delivery order is for the supply of 3,750 units of the 5 ml vial of the pharmaceutical product ASPARLAS, with a period of performance through February 3, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This award is not associated with any set-aside designation.

Generated 4/11/25, 11:04 AM